MedReleaf Australia chief executive Russell Harding tells Cannabiz of his latest plans for the company, discusses the thorny issue of imported product and expresses hope that subsidies may not be far away.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

When MedReleaf Australia formally announced itself to the local market in early 2018, it, like many, was eyeing rapid growth.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...